KU ADRC partners with BYU for Alzheimer’s blood test study
The University of Kansas Alzheimer’s Disease Research Center (KU ADRC) in the US has partnered with Brigham Young University (BYU)…
The University of Kansas Alzheimer’s Disease Research Center (KU ADRC) in the US has partnered with Brigham Young University (BYU)…
Nyxoah has introduced its Genio neurostimulator, which is intended for obstructive sleep apnoea (OSA) treatment in England, with the first…
Cala Health has finalised the initial closing of an oversubscribed growth round of $50m to support the expansion of patient access…
ESYA Labs has entered a collaboration with Alamar Biosciences for biomarker detection and quantification for inflammatory and neurological diseases. This…
ShiraTronics has commenced the pivotal RELIEV-CM2 CLINICAL Study of its implantable neuromodulation therapy, designed for chronic migraine treatment. The US…
US-based Neuralink has received approval to launch a new feasibility trial studying its brain implant linked with an assistive robotic…
Neuralink has received approval from Health Canada to launch the first global trial, ‘Canadian Precise Robotically Implanted Brain-Computer Interface’ (CAN-PRIME),…
In a new era of Alzheimer’s disease research, the emergence of blockbuster therapies like Eli Lilly’s Kisunla (donanemab) and Eisai…
GE HealthCare has announced the Food and Drug Administration (FDA) 510(k) clearance for its SIGNA MAGNUS magnetic resonance imaging (MRI)…
Veravas and Phanes Biotech have announced a partnership for the joint development of a blood-based tau pathology test for detecting…